Th10 cells and IL-10 can thus be utilized as an evidence-based immunological biomarker of disease activity in SLE patients, particularly for remote monitoring in secondary or tertiary healthcare facilities, where skilled immunologists may not be available physically. The gene discussed is IL10; the disease is systemic lupus erythematosus.